Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

1,318 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Characteristics of circulating KSHV-infected viroblasts during active KSHV+ multicentric Castleman disease.
Martin de Frémont G, Vanjak A, Sbihi Z, Knapp S, Garzaro M, Chbihi M, Fournier B, Poirot J, Dossier A, Silvestrini MA, Villemonteix J, Meignin V, Galicier L, Bertinchamp R, Le Goff J, Salmona M, Flamarion E, Cassius C, Lebbé C, Ronchetti AM, Latour S, Oksenhendler E, Carcelain G, Boutboul D. Martin de Frémont G, et al. Among authors: knapp s. Blood Adv. 2023 May 9;7(9):1682-1691. doi: 10.1182/bloodadvances.2022008456. Blood Adv. 2023. PMID: 36508281 Free PMC article.
Reply to Zhou et al. 'A novel approach for characterization of KSHV-associated multicentric Castleman disease from effusions'.
Vanjak A, Garzaro M, Knapp S, Silvestrini MA, Martin de Fremont G, Bertinchamp R, Calvani J, Meignin V, Dossier A, Galicier L, Oksenhendler E, Boutboul D. Vanjak A, et al. Among authors: knapp s. Br J Haematol. 2023 Apr;201(2):357-359. doi: 10.1111/bjh.18698. Epub 2023 Feb 14. Br J Haematol. 2023. PMID: 36786160 No abstract available.
Combined Flow-Fluorescence in situ hybridization to HHV-8 and EBV reveals the viral heterogeneity of primary effusion lymphoma.
Stammler R, Vacher L, Fournier B, Lemaire P, Chauvel C, Silvestrini MA, Knapp S, de Frémont GM, Meignin V, Salmona M, Legoff J, Vanjak A, Dunogué B, Urbain F, Lambotte O, Noël N, Gérard L, Oksenhendler E, Galicier L, Latour S, Boutboul D. Stammler R, et al. Among authors: knapp s. J Med Virol. 2024 Aug;96(8):e29836. doi: 10.1002/jmv.29836. J Med Virol. 2024. PMID: 39078052
Carfilzomib-associated thrombotic microangiopathy: clinical features and outcomes.
Joseph A, Harel S, Mesnard L, Rafat C, Knapp S, Rumpler A, Philipponnet C, Barba C, Rebibou JM, Buob D, Hertig A, Vargaftig J, Halimi JM, Arnulf B, Bretaud AS, Joly B, Grangé S, Coppo P. Joseph A, et al. Among authors: knapp s. Nephrol Dial Transplant. 2024 Nov 27;39(12):2067-2078. doi: 10.1093/ndt/gfae096. Nephrol Dial Transplant. 2024. PMID: 38658194
Critical assessment of LC3/GABARAP ligands used for degrader development and ligandability of LC3/GABARAP binding pockets.
Schwalm MP, Dopfer J, Kumar A, Greco FA, Bauer N, Löhr F, Heering J, Cano-Franco S, Lechner S, Hanke T, Jaser I, Morasch V, Lenz C, Fearon D, Marples PG, Tomlinson CWE, Brunello L, Saxena K, Adams NBP, von Delft F, Müller S, Stolz A, Proschak E, Kuster B, Knapp S, Rogov VV. Schwalm MP, et al. Among authors: knapp s. Nat Commun. 2024 Nov 25;15(1):10204. doi: 10.1038/s41467-024-54409-5. Nat Commun. 2024. PMID: 39587067 Free PMC article.
The endocannabinoid anandamide mediates anti-inflammatory effects through activation of NR4A nuclear receptors.
Teichmann T, Pflüger-Müller B, Giménez VMM, Sailer F, Dirks H, Zehr S, Warwick T, Brettner F, Munoz-Tello P, Zimmer A, Tegeder I, Thomas D, Gurke R, Günther S, Heering J, Proschak E, Geisslinger G, Bibli IS, Heringdorf DMZ, Manucha W, Windbergs M, Knapp S, Weigert A, Leisegang MS, Kojetin D, Brandes RP. Teichmann T, et al. Among authors: knapp s. Br J Pharmacol. 2024 Nov 19. doi: 10.1111/bph.17366. Online ahead of print. Br J Pharmacol. 2024. PMID: 39563075
Type-II kinase inhibitors that target Parkinson's Disease-associated LRRK2.
Raig ND, Surridge KJ, Sanz-Murillo M, Dederer V, Krämer A, Schwalm MP, Elson L, Chatterjee D, Mathea S, Hanke T, Leschziner AE, Reck-Peterson SL, Knapp S. Raig ND, et al. Among authors: knapp s. bioRxiv [Preprint]. 2024 Oct 31:2024.09.17.613365. doi: 10.1101/2024.09.17.613365. bioRxiv. 2024. PMID: 39554022 Free PMC article. Preprint.
Relationship Between Race, Predelivery Cardiology Care and Cardiovascular Outcomes in Pre-Eclampsia/Eclampsia Among a Commercially Insured Population.
Bolakale-Rufai IK, Knapp SM, Tucker-Edmonds B, Khan S, Brewer LC, Mohammed S, Johnson AE, Mazimba S, Addison D, Breathett K. Bolakale-Rufai IK, et al. Among authors: knapp sm. Circ Cardiovasc Qual Outcomes. 2024 Nov 11. doi: 10.1161/CIRCOUTCOMES.124.011643. Online ahead of print. Circ Cardiovasc Qual Outcomes. 2024. PMID: 39523944 Free article.
Exploring biodiversity through museomics.
Davis CC, Knapp S. Davis CC, et al. Among authors: knapp s. Nat Rev Genet. 2024 Nov 6. doi: 10.1038/s41576-024-00801-2. Online ahead of print. Nat Rev Genet. 2024. PMID: 39506143 No abstract available.
Thieno[3,2-b]pyridine: Attractive scaffold for highly selective inhibitors of underexplored protein kinases with variable binding mode.
Moyano PM, Kubina T, Paruch ŠO, Jarošková A, Novotný J, Skočková V, Ovesná P, Suchánková T, Prokofeva P, Kuster B, Šmída M, Chaikuad A, Krämer A, Knapp S, Souček K, Paruch K. Moyano PM, et al. Among authors: knapp s. Angew Chem Int Ed Engl. 2024 Nov 6:e202412786. doi: 10.1002/anie.202412786. Online ahead of print. Angew Chem Int Ed Engl. 2024. PMID: 39503260
1,318 results